Franklin Biotechnology Discovery A
One Franklin Parkway San Mateo CA 94403-1906
Map
Phone: 800-632-2301
| Category: | Health | | Fund Family: | Franklin Templeton Investments | | Net Assets: | 291.01M | | Year-to-Date Return: | 3.59% | | Yield: | 0.00% | | Morningstar Rating: |  | | Fund Inception Date: | 15-Sep-97 |
|
Evan S. McCulloch
Lead Manager since
15-Sep-97 | | | Evan McCulloch is the lead Portfolio Manager for Franklin World Health Sciences and Biotech Fund, as well as a Vice President of Franklin Advisers, Inc. He specializes in research and analysis of the health care industry including pharmaceuticals, health care information systems/Internet, and health care providers. Evan received his Bachelor's degree in economics from the University of California at Berkeley and is a designated Chartered Financial Analyst (CFA).Evan joined Franklin in 1992. |
| Min Initial Investment: | $1,000 | | Min Initial Investment, IRA: | $250 | | Min Initial Investment, AIP: | $50 | | Min Subsequent Investment: | NaN | | Min Subsequent Investment, IRA: | N/A | | Min Subsequent Investment, AIP: | N/A |
|
| |
| The investment seeks capital appreciation. The fund normally invests at least 80% of net assets in securities of biotechnology companies and discovery research firms. It may invest a substantial portion of assets in equity securities of smaller capitalization companies with a market capitalization of less than $1.5 billion, and may invest a small portion of assets in private or illiquid securities, such as late stage venture capital financings. The fund may also invest up to 20% of net assets in equity or debt securities of any type of foreign or U.S. issuer. It is nondiversified. |
| Last Dividend
| YFT_NOT_APPLICABLE_ABBREVIATION | | Last Cap Gain
(15-Dec-00):
| 0.19 | | Annual Holdings Turnover
| 45.57% | | Average for Category:
| 134.64% |
|
| Expense | FBDIX | Category
Avg | | Total Expense Ratio: | 1.35%
| 1.68% | | Max 12b1 Fee: | 0.25%
| N/A | | Max Front End Sales Load: | 5.75%
| 5.35% | | Max Deferred Sales Load: | %
| 2.88% | | 3 Yr Expense Projection*: |
$ 978 | $720 | | 5 Yr Expense Projection*: |
$ 1,272 | $1,077 | | 10 Yr Expense Projection*: |
$ 2,105 | $2,106 |
|
|
0.19% Nasdaq 
0.18%
Profile
